Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

NCT07549698 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Warm Autoimmune Hemolytic Anemia (WAIHA)
ITP - Immune Thrombocytopenia
Warm Autoimmune Hemolytic Anemia
Immune Thrombocytopenic Purpura

Interventions

BIOLOGICAL: CTX112

Sponsor

CRISPR Therapeutics AG